ArticleCancer medicine2026

Three-Year Long-Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice.

Hideko Ohama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.